milbactor 4 mg/10 mg film-coated tablets for small cats and kittens weighing at least 0.5 kg
krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 4, 10 mg/tablet - milbemycin oxime, combinations - cats - endoparasiticide
milprazon 16 mg/40 mg film-coated tablets for cats weighing at least 2 kg
krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 16, 40 mg/tablet - milbemycin oxime, combinations - cats - endoparasiticide
milprazon 4 mg/10 mg film-coated tablets for small cats and kittens weighing at least 0.5 kg
krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 4, 10 mg/tablet - milbemycin oxime, combinations - cats - endoparasiticide
prazitel 230/20 mg flavoured film-coated tablets for cats
chanelle pharmaceuticals manufacturing limited - pyrantel embonate ; praziquantel - film-coated tablet - 230, 20 mg/tablet - praziquantel, combinations - cats - endoparasiticide
wormaway 230/20 mg flavoured film-coated tablets for cats
chanelle pharmaceuticals manufacturing limited - pyrantel embonate ; praziquantel - film-coated tablet - 230, 20 mg/tablet - praziquantel, combinations - cats - endoparasiticide
thiafeline 2.5 mg film-coated tablets for cats
le vet beheer b.v. - thiamazole - film-coated tablet - 2.5 mg/tablet - thiamazole - cats - miscellaneous
thiafeline 5 mg film-coated tablets for cats
le vet beheer b.v. - thiamazole - film-coated tablet - 5 mg/tablet - thiamazole - cats - miscellaneous
glyxambi 25 mg/5 mg empagliflozin/linagliptin 25mg/5mg film coated tablet blister pack
boehringer ingelheim pty ltd - linagliptin, quantity: 5 mg; empagliflozin, quantity: 25 mg - tablet, film coated - excipient ingredients: purified talc; hypromellose; mannitol; crospovidone; titanium dioxide; magnesium stearate; copovidone; pregelatinised maize starch; macrogol 6000; iron oxide red; maize starch - glyxambi tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate (see sections 4.2 dose and method of administration and 5.1 pharmacodynamic properties ? clinical trials).
glyxambi 10 mg/5 mg empagliflozin/linagliptin 10mg/5mg film coated tablet blister pack
boehringer ingelheim pty ltd - empagliflozin, quantity: 10 mg; linagliptin, quantity: 5 mg - tablet, film coated - excipient ingredients: iron oxide yellow; macrogol 6000; hypromellose; crospovidone; maize starch; titanium dioxide; mannitol; purified talc; pregelatinised maize starch; copovidone; magnesium stearate - glyxambi tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate (see sections 4.2 dose and method of administration and 5.1 pharmacodynamic properties ? clinical trials).
voriconazole sandoz voriconazole 50mg film-coated tablet blister pack
sandoz pty ltd - voriconazole, quantity: 50 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; lactose monohydrate; magnesium stearate; pregelatinised maize starch; titanium dioxide; hypromellose; triacetin - voriconazole sandoz is indicated for treatment of the following fungal infections:,- invasive aspergillosis.,- serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,- serious fungal infections caused by scedosporium spp and fusarium spp.,- other serious fungal infections, in patients intolerant of, or refractory to, other therapy,- prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.,- this brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets. for dosing requirements for populations who require intravenous or oral suspension treatment see dosage and administration.